SCOPUS 정보 검색 플랫폼

Regenerative Medicine

Volumn 7, Issue 4, 2012, Pages 451-453

Improving oversight of innovative medical interventions in Texas, USA

(1) Levine, Aaron D a

a GEORGIA INSTITUTE OF TECHNOLOGY (United States)

Author keywords

Food and Drug Administration; medical innovation; regulation; stem cell; translation; unproven therapy

Indexed keywords

CLINICAL EFFECTIVENESS; EXPERIMENTAL THERAPY; HUMAN; INSTITUTIONAL REVIEW; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; UNITED STATES;

GOVERNMENT REGULATION; HUMANS; PATIENT SAFETY; PHYSICIANS; STEM CELL TRANSPLANTATION; TEXAS; THERAPIES, INVESTIGATIONAL; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84864220081 PISSN: 17460751 EISSN: 1746076X Source Type: Journal
DOI: 10.2217/rme.12.43 Document Type: Review

Times cited : (3)

References (14)

1
- 84891747784
- New York Times, NY, USA, 14 April 2012
- Park M. Texas board approves rules on use of stem cells. New York Times, NY, USA, 14 April 2012.
- Texas Board Approves Rules on Use of Stem Cells
- Park, M.¹

2
- 80053155574
- Texas prepares to fight for stem cells
- Cyranoski D. Texas prepares to fight for stem cells. Nature 477(7365), 377-378 (2011).
- (2011) Nature , vol.477 , Issue.7365 , pp. 377-378
- Cyranoski, D.¹

3
- 84857750844
- The darker side of stem cells
- The darker side of stem cells. Nature 483(7387), 5 (2012).
- (2012) Nature , vol.483 , Issue.7387 , pp. 5

4
- 84860801888
- Texas stem cell rules may impede clinical research
- Arnold C. Texas stem cell rules may impede clinical research. Lancet 379(9828), 1776 (2012).
- (2012) Lancet , vol.379 , Issue.9828 , pp. 1776
- Arnold, C.¹

5
- 84859789542
- Stem-cell therapy takes off in texas
- Cyranoski D. Stem-cell therapy takes off in Texas. Nature 483(7387), 13-14 (2012).
- (2012) Nature 483 , vol.7387 , Issue.13-14
- Cyranoski, D.¹

6
- 84859930680
- Stem cells
- Kaiser J. Stem cells. Texas Medical Board approves rules for controversial treatment. Science 336(6079), 284 (2012).
- (2012) Texas Medical Board Approves Rules for Controversial Treatment Science 336 , vol.6079 , Issue.284
- Kaiser, J.¹

7
- 56549103448
- Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine
- Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T. Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3(6), 591-594 (2008).
- (2008) Cell Stem. Cell , vol.3 , Issue.6 , pp. 591-594
- Lau, D.¹ Ogbogu, U.² Taylor, B.³ Stafinski, T.⁴ Menon, D.⁵ Caulfield, T.⁶

8
- 70349868339
- Medicine on the fringe: Stem cell-based interventions in advance of evidence
- Regenberg AC, Hutchinson LA, Schanker B, Mathews DJH. Medicine on the fringe: Stem cell-based interventions in advance of evidence. Stem Cells 27(9), 2312-2319 (2009).
- (2009) Stem Cells , vol.27 , Issue.9 , pp. 2312-2319
- Regenberg, A.C.¹ Hutchinson, L.A.² Schanker, B.³ Mathews, D.J.H.⁴

9
- 77649282317
- Tracking the rise of stem cell tourism
- Ryan KA, Sanders AN, Wang DD, Levine AD. Tracking the rise of stem cell tourism. Regen. Med. 5(1), 27-33 (2010).
- (2010) Regen. Med. , vol.5 , Issue.1 , pp. 27-33
- Ryan, K.A.¹ Sanders, A.N.² Wang, D.D.³ Levine, A.D.⁴

10
- 84355162178
- The unregulated commercialization of stem cell treatments: A global perspective
- Sipp D. The unregulated commercialization of stem cell treatments: A global perspective. Front. Med. 5(4), 348-355 (2011).
- (2011) Front. Med. , vol.5 , Issue.4 , pp. 348-355
- Sipp, D.¹

11
- 79955844403
- Stem cell stratagems in alternative medicine
- Sipp D. Stem cell stratagems in alternative medicine. Regen. Med. 6(3), 407-414 (2011).
- (2011) Regen. Med. , vol.6 , Issue.3 , pp. 407-414
- Sipp, D.¹

12
- 56749173982
- New ISSCR guidelines underscore major principles for responsible translational stem cell research
- Hyun I, Lindvall O, Ahrlund-Richter L et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3(6), 607-609 (2008).
- (2008) Cell Stem. Cell , vol.3 , Issue.6 , pp. 607-609
- Hyun, I.¹ Lindvall, O.² Ahrlund-Richter, L.³

13
- 80755156302
- Regulating autologous adult stem cells: The FDA steps up
- Lysaght T, Campbell AV. Regulating autologous adult stem cells: The FDA steps up. Cell Stem Cell 9(5), 393-396 (2011).
- (2011) Cell Stem. Cell , vol.9 , Issue.5 , pp. 393-396
- Lysaght, T.¹ Campbell, A.V.²

14
- 40449088049
- Medicine: Moving toward transparency of clinical trials
- DOI 10.1126/science.1153632
- Zarin DA, Tse T. Medicine. Moving toward transparency of clinical trials. Science 319(5868), 1340-1342 (2008). (Pubitemid 351354858)
- (2008) Science , vol.319 , Issue.5868 , pp. 1340-1342
- Zarin, D.A.¹ Tse, T.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.